Logo.PNG
Veritas Announces Binding Share Purchase Agreement with Leis Industries Limited for Sale of Sechelt Organic Marijuana
November 14, 2018 08:15 ET | Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered...
Logo.PNG
Veritas Confirms Readiness for Human Trials of CTL-X for Pain; Projected to Start Early Next Month
November 08, 2018 08:30 ET | Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that, despite the...
Logo.PNG
Frankfurt’s Clearstream Banking Lifts Settlement Restrictions on Securities Active in Medical Cannabis
August 08, 2018 03:30 ET | Veritas Pharma Inc.
VANCOUVER, British Columbia, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that Clearstream...
Logo.PNG
Veritas Appoints Mr. Filios Theodorou as Its Agent for Cyprus and SEMEA Countries
June 25, 2018 03:15 ET | Veritas Pharma Inc.
VANCOUVER, British Columbia, June 25, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that Mr. Filios...
Logo.PNG
Veritas Pharma Has Retained Cannabis Branding Firm for Design of Label and Packaging
May 15, 2018 17:06 ET | Veritas Pharma Inc.
VANCOUVER, British Columbia, May 15, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce with the dealer licence...
Logo.PNG
Dr. Michael K. Pugsley Joins Veritas Pharma’s Advisory Board
April 18, 2018 03:50 ET | Veritas Pharma Inc.
VANCOUVER, British Columbia, April 18, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that Dr. Michael K....
Logo.PNG
Veritas Pharma Closes Private Placement
March 29, 2018 03:10 ET | Veritas Pharma Inc.
VANCOUVER, British Columbia, March 29, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announces the closing of a...
Logo.PNG
Veritas Pharma Signs Letter of Intent with 3 Carbon Extractions Inc.
March 08, 2018 03:10 ET | Veritas Pharma Inc.
VANCOUVER, British Columbia, March 08, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announce the signing of a...
Logo.PNG
Veritas Pharma Signs Memorandum of Understanding with BioCan Technologies
February 28, 2018 03:05 ET | Veritas Pharma Inc.
VANCOUVER, British Columbia, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered into...
Logo.PNG
Veritas Pharma Subsidiary Receives Health Canada Dealer Licence
December 28, 2017 03:05 ET | Veritas Pharma Inc.
VANCOUVER, British Columbia, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces that Health Canada has issued its...